• Find an Expert
  • Contact
  • SearchSearch icon
  • Menu
  • Help
  • Report an issue

Conference Proceedings

Contribution of various relapse phenotypes to disability in multiple sclerosis

Tomas Kalincik, Tamasine Stewart, Vilija Jokubaitis, Tim Spelman, Jeannette Lechner-Scott, Mark Slee, Suzanne Hodgkinson, Pamela McCombe, Michael Barnett, Steve Vucic, Neil Shuey, Cameron Shaw, Helmut Butzkueven

MULTIPLE SCLEROSIS JOURNAL | SAGE PUBLICATIONS LTD | Published : 2015

University of Melbourne Researchers

Tomas Kalincik's Profile Picture
Tomas Kalincik Author

Timothy Spelman's Profile Picture
Timothy Spelman Author

Neil Shuey's Profile Picture
Neil Shuey Author

Related Projects (3)

Project icon

Is MS treatment effective long-term?

Multiple Sclerosis is an illness affecting more than 20,000 Australians, and causes significant disability and social disruption in most suf..

Project icon

CENTRE FOR TRANSLATIONAL NEUROSCIENCE: A MODULAR PLATFORM FOR TRANSLATING DISCOVERY INTO HEALTH OUTCOMES

Clinical Centre of Research Excellence in Translational Neuroscience will provide people, pathways and resources to create a novel platform ..

Project icon

TREATING PROGRESSIVE MULTIPLE SCLEROSIS

While there are numerous therapies for relapsing-remitting multiple sclerosis (MS), therapy for progressive MS remains elusive. This project..

Keywords

Disability Relapses Phenotype
Neurosciences
Neurosciences & Neurology
Science & Technology
Clinical Neurology
Life Sciences & Biomedicine

We acknowledge and pay respect to the Traditional Owners of the lands upon which our campuses are situated

Read about our commitment to reconciliation  

About us  

Careers at Melbourne  

Safety and respect  

Newsroom  

Contact  

Phone: 13 MELB ( 13 6352)

International: +61 3 9035 5511


Address:
The University of Melbourne
Grattan Street, Parkville,
Victoria, 3010, Australia


View all Campus locations  
facebookIconlinkedinIconinstagramIcontwitterIcon

Emergency information  |  Disclaimer and copyright  |  Accessibility  |  Privacy  |  VaxFACTS

CRICOS number: 00116K     ABN: 84 002 705 224